Earnings | Dabur India Ltd. (NSE: DABUR): Q3FY23 Results Out; Total Income rise 3% YoY

Dabur India Ltd. (NSE: DABUR) is a leading consumer goods company in India that offers products in the healthcare, personal care, home care, and foods categories. The company’s portfolio includes popular brands such as Dabur Amla, Vatika, Real, and Fem. It has a strong presence in India and other countries, including the Middle East, Africa, and Asia. Dabur India Ltd. is known for its emphasis on natural and ayurvedic ingredients in its products.

Dabur India Ltd, reported a 3.4% growth in revenue for Q3FY23, crossing the Rs 3,000 crore mark for the first time in a quarter. Despite a challenging cost and operating environment, the company posted a constant currency growth of 5.7%, driven by overall consumer sentiments. The net profit for the third quarter stood at Rs 476 crore, with a 3-year CAGR at 6.1%. For the period ended December 31, 2022, Dabur India reported a total income of Rs. 3144.01 crore, compared to Rs. 3109.7 crore for the period ended September 30, 2022. The company’s net profit for the period ended December 31, 2022, stood at Rs. 475.94 crore, down from Rs. 490.06 crore for the period ended September 30, 2022. The company reported an EPS of Rs. 2.68 for the period ended December 31, 2022, compared to Rs. 2.76 for the period ended September 30, 2022. Despite the challenging operating environment, Dabur India remains optimistic about its growth prospects, driven by its strong portfolio of brands and continued investments in R&D and marketing. The company is focused on expanding its presence in India’s fast-growing consumer market, as well as increasing its global footprint through strategic partnerships and acquisitions.

Chief Executive Officer Mr. Mohit Malhotra said. : “We have delivered steady results in what continues to be a difficult cost and operating environment. We continued to adjust prices responsibly to reflect inflation, Our India business reported a growth of 3.3% with a 3-year CAGR of 9.5% and steady market share gains across the portfolio, despite most operating categories reporting a decline,”.